Aion Diagnostics, Ltd.
Plans created by pSivida spinout for development of biosensors, imaging products
Published in Medical Imaging Business Week, January 5th, 2006
The first of these products is expected to be marketed in 2008. Aion has already started discussions with the U.S. Food and Drug Administration (FDA).
Aion has also moved its primary place of incorporation to the U.S, the world's largest healthcare and financial market, while creating a new Australian subsidiary. Aion Diagnostics, Inc., is a wholly owned subsidiary of global bionanotech company, pSivida Limited (PSDV, PSD, PSI) and owns the rights to commercialize diagnostics...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
More Articles from Medical Imaging Business Week
- Alliance Imaging, Inc.
Diagnostic imaging services firm expects revenues to range from $428M to $438M - ATI Technologies, Inc.
Confirma selects FireGL graphics to power CADstream - i3ARCHIVE, Inc.
Company expands digital medical archiving system to enable imaging disaster recovery - Palatin Technologies, Inc.
Biopharma company discusses potential health risk associated with NeutroSpec - Smith & Nephew, Inc.
Court grants preliminary injunction in meniscus repair system patent case - Age Related Macular Degeneration
Triamcinolone acetonide and vitrectomy may manage subfoveal choroidal neovascularization - More from this issue of Medical Imaging Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
